Episodes
Saturday Mar 02, 2024
Saturday Mar 02, 2024
Pharmacists are the most accessible health professionals and can play a vital role in screening and managing hypertension. But would an expanded scope of practice that enabled pharmacists to prescribe and manage antihypertensive therapies be cost-effective?
Guest Authors: Stefania Cian, PharmD and Candice Garwood, PharmD, FCCP, BCPS, BCACP
Special Guest: Dave Dixon, PharmD, BCACP, CLS
Music by Good Talk
Friday Feb 02, 2024
Friday Feb 02, 2024
Most clinical settings now use oscillometric BP devices to measure patients’ BP, and over half of people with hypertension (HTN) use a home BP monitor. Can we trust these BP readings if an inappropriate cuff size was used? How will this impact the way we assess BP control?
Guest Authors: Vincent Lam, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP, CDCES
Music by Good Talk
Friday Dec 01, 2023
Complex Patient Case 3: Treatment Resistant Hypertension
Friday Dec 01, 2023
Friday Dec 01, 2023
Reason for Visit: JT was referred by his PCP to the ambulatory care pharmacist for hypertension management.
Chief complaint: “My medication is making my mouth dry. I want to stop it.”
Guest Authors: Sabrina Silviera, PharmD and Megan Scalia, PharmD, BCACP
Expert Panelists: Eric MacLaughlin, PharmD, BCPS and Joseph Saseen, PharmD, BCPS, BCACP, CLS
Music by Good Talk
Friday Nov 03, 2023
Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure?
Friday Nov 03, 2023
Friday Nov 03, 2023
Do pharmacists providing remote care using telehealth technologies to patients who self-monitor their blood pressure perform as well as physicians and care managers providing care face-to-face? Is BP control better (or worse)? What about patient satisfaction? The Hyperlink 3 study provides more evidence the telehealth is safe and effective ... and patients prefer it.
Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS, and Jessica Wooster, PharmD, BCACP
Music by Good Talk
Friday Oct 06, 2023
Over-the-Counter Hearing Aids – Where Do They Fit?
Friday Oct 06, 2023
Friday Oct 06, 2023
Approximately 1 in 6 adults in the United States report some trouble with their hearing. Despite the prevalence and implications of hearing loss, hearing aid use is strikingly low due to cost and accessibility. In late 2022, the FDA finalized regulations for over-the-counter hearing aids to be sold without medical evaluation or the services of a hearing professional. But will self-fitting OTC hearing aids be as effective as audiologist-fitted prescription hearing aids?
Guest Authors: Lucas A. Berenbrock, PharmD, MS, BCACP and Elaine Mormer, PhD, CCC-A
Music by Good Talk
Friday Aug 11, 2023
Making the GRADE: Durability of Glycemic Response in Type 2 Diabetes
Friday Aug 11, 2023
Friday Aug 11, 2023
Type 2 diabetes (type 2 DM) is a progressive disease caused by a variety of pathophysiologic defects. However, even with substantial advances in treatment, glycemic control remains elusive, and most patients require combination therapy. The Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness (GRADE) study sought to investigate the glucose-lowering efficacy of several diabetes medications in combination with metformin.
Guest Authors: Katelyn Currier, PharmD and Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM
Music by Good Talk
Friday Apr 14, 2023
Friday Apr 14, 2023
You’ve probably encountered many patients who have experienced muscle symptoms after starting a statin. Statin-associated muscle symptoms (SAMS) contribute to treatment discontinuation and significantly increase cardiovascular (CV) adverse events and mortality. What strategies do you recommend to increase statin tolerance?
Guest Author: Rick Hess, PharmD, CDCES, BCACP
Music by Good Talk
Thursday Mar 23, 2023
Thursday Mar 23, 2023
Patient for pharmacists' patient care services remains a challenge. While provider status at the federal level has not yet been realized, there has been a steady growth of payers and programs covering services provided by pharmacists in recent years.
Guest Author: E. Michael Murphy, PharmD, MBA
Music by Good Talk
Friday Feb 03, 2023
Friday Feb 03, 2023
Hyperkalemia is a common electrolyte disorder in patients with CKD that can be exacerbated by renin-angiotensin-aldosterone system (RAAS) inhibitors. While hyperkalemia poses potential risks to patients with CKD, the potentially negative impact of discontinuing RAAS inhibitor therapy on long-term renal and cardiovascular outcomes in CKD patients is unclear.
Guest Author: Michelle A. Fravel, PharmD, BCPS
Music by Good Talk
Friday Sep 16, 2022
Friday Sep 16, 2022
Unsurprisingly, medication burden increases as we age. At each clinic visit, we consider starting new medications, but it’s still relatively uncommon to critically evaluate medications that could be deprescribed. How can we change the culture to embrace deprescribing as an integral part of patient care? The OPTIMIZE study was a provider- and patient-level educational intervention that attempted to increase deprescribing.
Guest Authors: Kashelle Lockman, PharmD, MA and Sarah Greiner, PharmD
Music by Good Talk